DIMENSIONAL FUND ADVISORS LP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 103 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,224,827
-22.9%
672,057
-23.8%
0.00%0.0%
Q1 2024$2,884,827
-20.9%
882,210
-15.1%
0.00%0.0%
Q4 2023$3,646,023
-54.7%
1,038,652
-13.8%
0.00%
-66.7%
Q3 2023$8,048,074
-14.8%
1,205,024
+7.1%
0.00%0.0%
Q2 2023$9,442,429
-15.3%
1,125,645
+0.2%
0.00%
-25.0%
Q1 2023$11,148,957
+179838.0%
1,122,908
+26.1%
0.00%
+100.0%
Q4 2022$6,196
-99.8%
890,232
+30.9%
0.00%
+100.0%
Q3 2022$3,632,000
+997.3%
680,013
+720.1%
0.00%
Q2 2022$331,000
-55.6%
82,920
-50.5%
0.00%
Q1 2022$745,000
-28.2%
167,619
-35.4%
0.00%
Q4 2021$1,038,000
-56.4%
259,618
-4.3%
0.00%
-100.0%
Q3 2021$2,383,000
-22.5%
271,3840.0%0.00%0.0%
Q2 2021$3,075,000
-5.8%
271,384
-1.3%
0.00%0.0%
Q1 2021$3,265,000
+77.5%
274,835
+2.5%
0.00%0.0%
Q4 2020$1,839,000
+8.9%
268,032
+17.6%
0.00%0.0%
Q3 2020$1,688,000
+93.1%
227,842
+8.7%
0.00%
Q2 2020$874,000
+81.7%
209,577
+7.5%
0.00%
Q1 2020$481,000
-65.5%
194,927
-18.8%
0.00%
-100.0%
Q4 2019$1,395,000
+33.5%
240,123
+21.0%
0.00%
Q3 2019$1,045,000
+2.2%
198,384
+16.3%
0.00%
Q2 2019$1,023,000
+201.8%
170,537
+317.2%
0.00%
Q4 2018$339,000
-72.7%
40,875
-54.5%
0.00%
Q3 2018$1,241,000
+150.2%
89,911
+44.0%
0.00%
Q2 2018$496,000
+6.0%
62,4290.0%0.00%
Q1 2018$468,000
+35.3%
62,429
+22.6%
0.00%
Q4 2017$346,00050,9230.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 1,877,305$10,025,0005.86%
Prosight Management, LP 1,210,800$6,466,0003.46%
Perceptive Advisors 11,350,085$60,609,0001.76%
JOHNSON & JOHNSON 394,834$2,108,0000.62%
TANG CAPITAL MANAGEMENT LLC 700,000$3,738,0000.46%
APOGEM CAPITAL LLC 85,091$454,0000.45%
683 Capital Management, LLC 700,000$3,738,0000.29%
EAM Investors, LLC 233,638$1,248,0000.27%
Verition Fund Management LLC 4,804,478$12,840,8280.14%
WOODSTOCK CORP 129,179$690,0000.10%
View complete list of ALDEYRA THERAPEUTICS INC shareholders